Harri M Itkonen

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Molecular cancer research : MCR

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Glycobiology

Scientific reports

Harvard Medical School

University of Oslo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School May 10 2017 - Mar 31 2019

United States

Research Fellow :: Department of Microbiology and Immunobiology

University of Oslo May 10 2014 - May 09 2017

Norway

Postdoctoral researcher :: Centre for Molecular Medicine Norway

Education History

University of Oslo Jun 15 2010 - May 14 2014

Norway

PHD :: Centre for Molecular Medicine Norway

University of Eastern Finland Sep 01 2004 - May 31 2010

Finland

MSC :: Department of Environmental and Biological Sciences

Publications

Shivani Yalala, Aishwarya Gondane, Ninu Poulose, Jing Liang, Ian Geoffrey Mills, Harri M Itkonen
CDK9 inhibition activates innate immune response through viral mimicry. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (8) (2024)
Shivani Yalala, Aishwarya Gondane, Ninu Poulose, Jing Liang, Ian Geoffrey Mills, Harri M Itkonen
CDK9 inhibition activates innate immune response through viral mimicry. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (8) (2024)
Jing Liang, Aishwarya Gondane, Harri M Itkonen
CDK12-inactivation-induced MYC signaling causes dependency on the splicing kinase SRPK1. Molecular oncology (2024)
Satu Pallasaho, Aishwarya Gondane, Anni Kuivalainen, Samuel Girmay, Siver Moestue, Massimo Loda, Harri M Itkonen
Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. Journal of cancer research and clinical oncology (2022)
Aishwarya Gondane, Ninu Poulose, Suzanne Walker, Ian G Mills, Harri M Itkonen
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition. Glycobiology 32 (9) (2022)
Harri M Itkonen, Massimo Loda, Ian Geoffrey Mills
O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene? Molecular cancer research : MCR 19 (4) (2021)
Qiang Hu, Ninu Poulose, Samuel Girmay, Alma Helevä, Dimitrios Doultsinos, Aishwarya Gondane, Rebecca E Steele, Xiaozhuo Liu, Massimo Loda, Song Liu, Dean G Tang, Ian G Mills, Harri M Itkonen
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells. RNA biology (2021)
Harri M Itkonen, Ninu Poulose, Rebecca E Steele, Sara E S Martin, Zebulon G Levine, Damien Y Duveau, Ryan Carelli, Reema Singh, Alfonso Urbanucci, Massimo Loda, Craig J Thomas, Ian Geoffrey Mills, Suzanne Walker
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. Molecular cancer research : MCR 18 (10) (2020)
Anna Barkovskaya, Kotryna Seip, Bylgja Hilmarsdottir, Gunhild M Maelandsmo, Siver A Moestue, Harri M Itkonen
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes. Scientific reports 9 (1) (2019)

Harri M Itkonen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Harri M Itkonen